Carmen Capote-Gasca
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Persistent elite controllers as the key model to identify permanent HIV remission.
Journal: Current opinion in HIV and AIDS
Published: January 08, 2025
Maraviroc treatment for hospitalized participants with non-severe COVID-19 at risk of progression: a randomized, proof-of-concept clinical trial.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: January 07, 2025
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
Journal: PloS one
Published: November 21, 2024
SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.
Journal: Frontiers in immunology
Published: October 07, 2024
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection.
Journal: The Journal of experimental medicine
Published: June 26, 2024
HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1.
Journal: EBioMedicine
Published: May 08, 2024
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size.
Journal: JCI insight
Published: April 23, 2024
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
Journal: The Journal of clinical investigation
Published: July 25, 2023
A metagenome-wide association study of HIV disease progression in HIV controllers.
Journal: iScience
Published: April 04, 2023
Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.
Journal: EBioMedicine
Published: July 14, 2022
Last Updated: 09/26/2026